Show simple item record

dc.contributor.authorSen, F.
dc.contributor.authorCakar, B.
dc.contributor.authorHizal, M.
dc.contributor.authorEraslan, E.
dc.contributor.authorAksoy, S.
dc.contributor.authorPaydas, S.
dc.contributor.authorDemir, N.
dc.contributor.authorBulut, G.
dc.contributor.authorGokmen, E.
dc.contributor.authorOzer, L.
dc.contributor.authorOkten, I. N.
dc.contributor.authorEkinci, F.
dc.contributor.authorDisel, U.
dc.contributor.authorOzkan, M.
dc.contributor.authorErdem, D.
dc.contributor.authorSakin, A.
dc.contributor.authorOzdemir, N.
dc.contributor.authorUluc, B. Oyan
dc.contributor.authorOruc, K.
dc.contributor.authorSendur, M. A. N.
dc.date.accessioned2021-12-10T12:40:50Z
dc.date.available2021-12-10T12:40:50Z
dc.identifier.citationSendur M. A. N. , Cakar B., Hizal M., Eraslan E., Aksoy S., Paydas S., Demir N., Sen F., Bulut G., Oruc K., et al., "Talazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey", ANNALS OF ONCOLOGY, cilt.32, 2021
dc.identifier.issn0923-7534
dc.identifier.otherav_ceea8332-e5a0-4b46-b1f9-d42812e6194b
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/174405
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2021.03.138
dc.language.isoeng
dc.subjectOncology
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectHealth Sciences
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.titleTalazoparib in locally advanced or metastatic breast cancer patients: Experience from an early access program in Turkey
dc.typeMakale
dc.relation.journalANNALS OF ONCOLOGY
dc.contributor.departmentAntalya Training & Research Hospital , ,
dc.identifier.volume32
dc.contributor.firstauthorID2634695


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record